The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have reported that patients in 23 states could have been exposed to medications that may be tainted with a fungal form of meningitis.
It is reported that 35 people in six states have a non-contagious, fungal form of meningitis. What is common among all the patients is that each had been injected with a steroid called methylprednisolone acetate, which is made by New England Compounding Center (NECC) in Massachusetts.
Officials say that approximately 75 medical facilities in those states have received products by the NECC. Pennsylvania is one of those states.
According to an article on CNN.com, the FDA is advising all health care professionals who may have received medications from NECC to not use any NECC products. Federal health inspectors were at the NECC plant. The investigation is still underway.
Officials recommend that anyone who thinks they may have recently received a steroid injection in the lower back should contact their physician to see if the products were from NECC.